Chemical modificomics: a novel strategy for efficient biomarker discovery through chemical modifications on a target peptide
- 25 May 2012
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 4 (7) , 1945-1952
Abstract
This manuscript describes a proof-of-concept study to develop a novel “omics” strategy, referred to as “chemical modificomics”, for efficient biomarker discovery. Proteins and peptides are exposed to higher chemical stresses during some physiological events, such as increased oxidative stress from the degenerative diseases of aging. Therefore, the resulting chemical modifications can provide significant information about biological events. However, quantitative analyses of bioactive peptides and proteins in specific diseases have relied almost exclusively on the use of immunoassay-based procedures, without concern for possible chemical modifications and subsequent changes of activity/conformation. Therefore, we focused only on specific bioactive peptides and proteins closely related to a target disease, and exhaustively screened all chemical modifications for efficient biomarker discovery. The strategy involves two tactics: (1) backbone-specific clean-up methodology by recycling commercially available antibodies and (2) mass spectrometric screening methodology to provide an overview of unknown chemical modifications on a specific target. In this study, seven chemically modified angiotensin (Ang) IIs were employed as model compounds. The clean-up was conducted by immunoaffinity purification using commercially available anti-Ang II antibody (polyclonal). Screening was then performed by precursor ion scan using y2 ion, which is a common C-terminal fragment without including the modifications. This strategy can be simply applied to screen various chemical modifications including posttranslational modifications on a specific peptide and protein analyzed by immunological methods.Keywords
This publication has 47 references indexed in Scilit:
- Quantitative phosphoproteomics strategies for understanding protein kinase-mediated signal transduction pathwaysExpert Review of Proteomics, 2011
- A strategy for discovery of cancer glyco‐biomarkers in serum using newly developed technologies for glycoproteomicsThe FEBS Journal, 2009
- Toward an “omic” physiopathology of reactive chemicals: Thirty years of mass spectrometric study of the protein adducts with endogenous and xenobiotic compoundsMass Spectrometry Reviews, 2009
- Targeted proteomics for validation of biomarkers in clinical samplesBriefings in Functional Genomics and Proteomics, 2008
- Comparative glycoproteomics: approaches and applicationsBriefings in Functional Genomics and Proteomics, 2008
- Finding the needle in the haystackNature Reviews Cancer, 2008
- The plasma proteome, adductome and idiosyncratic toxicity in toxicoproteomics researchBriefings in Functional Genomics and Proteomics, 2008
- Quantitative mass spectrometry in proteomics: a critical reviewAnalytical and Bioanalytical Chemistry, 2007
- Proteomics in biomarker discovery and drug developmentJournal of Cellular Biochemistry, 2003
- The Human Plasma ProteomeMolecular & Cellular Proteomics, 2002